More on crsp
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $59.81 |
|
|||
| Open | $58.73 | ||||
| 52 Wk High | $18.88 | ||||
| 52 Wk Low | $13.75 | ||||
| Day High | $60.90 | ||||
| Day Low | $56.94 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,910,082 | ||||
- Form SCHEDULE 13G/A CRISPR Therapeutics AG Filed by: ORBIS INVESTMENT MANAGEMENT LTD
- Form 4 CRISPR Therapeutics AG For: Aug 07 Filed by: Prasad Raju
- Agomab proposes two new board members ahead of shareholder vote
- Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
- Agomab proposes two new board members ahead of shareholder vote
- Form 10-Q CRISPR Therapeutics AG For: Jun 30
- CRISPR Therapeutics (CRSP) Tops Q2 EPS by 26c
- Form 8-K CRISPR Therapeutics AG For: Aug 03
- CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
- Form SCHEDULE 13G/A CRISPR Therapeutics AG Filed by: BlackRock, Inc.
Entities mentioned with crsp
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Goldman Sachs | View Related Stories »
- 13G | View Related Stories »
- Show More...
